CompuMed, Inc.
CMPD · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $5,018 | $5,021 | $4,779 | $2,712 |
| - Cash | $1,416 | $1,450 | $1,564 | $1,293 |
| + Debt | $844 | $460 | $523 | $327 |
| Enterprise Value | $4,446 | $4,031 | $3,738 | $1,746 |
| Revenue | $1,867 | $1,666 | $1,619 | $1,644 |
| % Growth | 12.1% | 2.9% | -1.6% | – |
| Gross Profit | $848 | $780 | $766 | $800 |
| % Margin | 45.4% | 46.8% | 47.3% | 48.6% |
| EBITDA | $298 | $208 | $219 | $285 |
| % Margin | 15.9% | 12.5% | 13.5% | 17.3% |
| Net Income | $59 | $23 | $30 | $101 |
| % Margin | 3.1% | 1.4% | 1.8% | 6.1% |
| EPS Diluted | 0.044 | 0.017 | 0.023 | 0.077 |
| % Growth | 158.1% | -24.2% | -70.4% | – |
| Operating Cash Flow | $321 | $56 | $247 | $509 |
| Capital Expenditures | -$739 | -$117 | -$172 | -$224 |
| Free Cash Flow | -$418 | -$61 | $75 | $285 |